Drug profile · INN
leflunomide
APO-LEFLUNOMIDE
- US status
- approved
- Patents linked
- 3
- News articles
- 0
Quick answer
leflunomide (APO-LEFLUNOMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN leflunomide
Brand APO-LEFLUNOMIDE
Route ORAL
Formulation TABLET
ATC code L04AK01
Originator Alphapharm Pty Ltd
Related patents
Search patents →Frequently asked questions
What is leflunomide?
leflunomide (APO-LEFLUNOMIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Alphapharm Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for leflunomide?
APO-LEFLUNOMIDE is a marketed brand name for leflunomide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of leflunomide?
leflunomide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.